Contents

Current Cancer Therapy Reviews, Volume 3 - Number 4

Editorial [ The Role of Epidermal Growth Factor Receptor (EGFR) Targeting Drugs in the Treatment of Cancer Guest Editor: Fortunato Ciardiello ]

, 3(4): 223 - 225

Fortunato Ciardiello and Giampaolo Tortora


DOI: 10.2174/157339407782497040




Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment

, 3(4): 226 - 235

Clorinda Schettino, Maria Anna Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli


DOI: 10.2174/157339407782496997




Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity

, 3(4): 236 - 241

Teresa Troiani, Tina Cascone, John Heymach and Fortunato Ciardiello


DOI: 10.2174/157339407782496979




Cetuximab, A Chimeric Anti-Epidermal Growth Factor Receptor Monoclonal Antibody, in Colorectal Cancer Treatment

, 3(4): 242 - 248

Erika Martinelli, Michele Orditura, Ferdinando De Vita, Gennaro Galizia and Fortunato Ciardiello


DOI: 10.2174/157339407782497068




Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab

, 3(4): 249 - 254

Andrea Sartore-Bianchi, Andrea Sporchia, Giulio Cerea, Maria Rosaria Maugeri, Tiziana Cipani, Ines Andreotti, Giovanna Marrapese, Salvatore Artale and Salvatore Siena


DOI: 10.2174/157339407782497022




EGFR Inhibitors and Radiation in HNSCC

, 3(4): 255 - 266

Laura QM Chow, Changhu Chen and David Raben


DOI: 10.2174/157339407782497004




Optimizing Anti-EGFR Strategies in Cancer Treatment

, 3(4): 267 - 275

Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo


DOI: 10.2174/157339407782497059




Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors

, 3(4): 276 - 283

Floriana Morgillo, Giampaolo Tortora and Fortunato Ciardiello


DOI: 10.2174/157339407782496988




Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy

, 3(4): 284 - 291

Maria Pia Morelli, Jennifer Spratlin and S. Gail Eckhardt


DOI: 10.2174/157339407782497013




Methodological Issues of Clinical Research with EGFR Inhibitors

, 3(4): 292 - 302

Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno and Francesco Perrone


DOI: 10.2174/157339407782497031




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science